Alpelisib in der Therapie des metastasierten PIK3CA-mutierten Mammakarzinoms: finale Auswertung des Gesamtüberlebens in der SOLAR-1-Studie

Translated title of the contribution: Alpelisib in the treatment of metastatic PIK3CA-mutated breast cancer: final analysis of overall survival in the SOLAR-1 study

Dieter M. Matlac*, Natalia Krawczyk, Lars Hanker, Achim Rody, Maggie Banys‑Paluchowski

*Corresponding author for this work
Translated title of the contributionAlpelisib in the treatment of metastatic PIK3CA-mutated breast cancer: final analysis of overall survival in the SOLAR-1 study
Original languageGerman
JournalOnkologe
Volume27
Issue number9
Pages (from-to)936-940
Number of pages5
ISSN0947-8965
DOIs
Publication statusPublished - 09.2021

Research Areas and Centers

  • Research Area: Luebeck Integrated Oncology Network (LION)
  • Centers: University Cancer Center Schleswig-Holstein (UCCSH)

DFG Research Classification Scheme

  • 2.22-21 Gynaecology and Obstetrics
  • 2.22-14 Hematology, Oncology
  • 2.22-08 Pharmacy

Cite this